These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 31720422)
1. Systematic screening for tuberculosis among hospital outpatients in Cameroon: The role of screening and testing algorithms to improve case detection. Sander MS; Laah SN; Titahong CN; Lele C; Kinge T; de Jong BC; Abena JF; Codlin AJ; Creswell J J Clin Tuberc Other Mycobact Dis; 2019 May; 15():100095. PubMed ID: 31720422 [TBL] [Abstract][Full Text] [Related]
2. Tuberculosis in people newly diagnosed with HIV at a large HIV care and treatment center in Northwest Cameroon: Burden, comparative screening and diagnostic yields, and patient outcomes. Mbu ET; Sauter F; Zoufaly A; Bronsvoort BMC; Morgan KL; Noeske J; Abena JF; Sander MS PLoS One; 2018; 13(6):e0199634. PubMed ID: 29944701 [TBL] [Abstract][Full Text] [Related]
3. Screening tests for active pulmonary tuberculosis in children. Vonasek B; Ness T; Takwoingi Y; Kay AW; van Wyk SS; Ouellette L; Marais BJ; Steingart KR; Mandalakas AM Cochrane Database Syst Rev; 2021 Jun; 6(6):CD013693. PubMed ID: 34180536 [TBL] [Abstract][Full Text] [Related]
4. Chest X-ray interpretation does not complement Xpert MTB/RIF in diagnosis of smear-negative pulmonary tuberculosis among TB-HIV co-infected adults in a resource-limited setting. Nakiyingi L; Bwanika JM; Ssengooba W; Mubiru F; Nakanjako D; Joloba ML; Mayanja-Kizza H; Manabe YC BMC Infect Dis; 2021 Jan; 21(1):63. PubMed ID: 33435896 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of bacteriologically confirmed pulmonary tuberculosis in South Africa, 2017-19: a multistage, cluster-based, cross-sectional survey. Moyo S; Ismail F; Van der Walt M; Ismail N; Mkhondo N; Dlamini S; Mthiyane T; Chikovore J; Oladimeji O; Mametja D; Maribe P; Seocharan I; Ximiya P; Law I; Tadolini M; Zuma K; Manda S; Sismanidis C; Pillay Y; Mvusi L Lancet Infect Dis; 2022 Aug; 22(8):1172-1180. PubMed ID: 35594897 [TBL] [Abstract][Full Text] [Related]
6. Tuberculosis prevalence after 4 years of population-wide systematic TB symptom screening and universal testing and treatment for HIV in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: A cross-sectional survey (TREATS). Klinkenberg E; Floyd S; Shanaube K; Mureithi L; Gachie T; de Haas P; Kosloff B; Dodd PJ; Ruperez M; Wapamesa C; Burnett JM; Kalisvaart N; Kasese N; Vermaak R; Schaap A; Fidler S; Hayes R; Ayles H; PLoS Med; 2023 Sep; 20(9):e1004278. PubMed ID: 37682971 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic Accuracy of the Truenat MTB Plus Assay and Comparison with the Xpert MTB/RIF Assay to Detect Tuberculosis among Hospital Outpatients in Cameroon. Ngangue YR; Mbuli C; Neh A; Nshom E; Koudjou A; Palmer D; Ndi NN; Qin ZZ; Creswell J; Mbassa V; Vuchas C; Sander M J Clin Microbiol; 2022 Aug; 60(8):e0015522. PubMed ID: 35861529 [TBL] [Abstract][Full Text] [Related]
8. Provider initiated tuberculosis case finding in outpatient departments of health care facilities in Ghana: yield by screening strategy and target group. Ohene SA; Bonsu F; Hanson-Nortey NN; Toonstra A; Sackey A; Lonnroth K; Uplekar M; Danso S; Mensah G; Afutu F; Klatser P; Bakker M BMC Infect Dis; 2017 Dec; 17(1):739. PubMed ID: 29191155 [TBL] [Abstract][Full Text] [Related]
9. Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF. Orlando S; Triulzi I; Ciccacci F; Palla I; Palombi L; Marazzi MC; Giuliano M; Floridia M; Mancinelli S; Mutemba E; Turchetti G PLoS One; 2018; 13(7):e0200523. PubMed ID: 30024890 [TBL] [Abstract][Full Text] [Related]
10. Algorithms for Screening for Active Tuberculosis among Individuals with Latent Tuberculosis Infection in a Rural Community in China. Xin H; Du Y; Cao X; Wang D; Zhang B; Zhang H; Feng B; He Y; He Y; Quan Z; Liu Z; Yan J; Guan L; Guan X; Shen F; Liu J; Jin Q; Pan S; Gao L Microbiol Spectr; 2022 Dec; 10(6):e0296722. PubMed ID: 36445141 [TBL] [Abstract][Full Text] [Related]
11. Impact of Xpert MTB/RIF in the Diagnosis of Childhood Tuberculosis in Rural Ethiopia. Pérez-Butragueño M; Ramos-Rincón JM; Tesfamariam A; Comeche B; Mohammed N; Tiziano G; Endirays J; Biru D; Elala T; Edri A; Prieto L; Górgolas M J Trop Pediatr; 2022 Jun; 68(4):. PubMed ID: 35848941 [TBL] [Abstract][Full Text] [Related]
12. Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms. Shapiro AE; Ross JM; Yao M; Schiller I; Kohli M; Dendukuri N; Steingart KR; Horne DJ Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013694. PubMed ID: 33755189 [TBL] [Abstract][Full Text] [Related]
13. Intensified tuberculosis case-finding in HIV-positive adults managed at Ethiopian health centers: diagnostic yield of Xpert MTB/RIF compared with smear microscopy and liquid culture. Balcha TT; Sturegård E; Winqvist N; Skogmar S; Reepalu A; Jemal ZH; Tibesso G; Schön T; Björkman P PLoS One; 2014; 9(1):e85478. PubMed ID: 24465572 [TBL] [Abstract][Full Text] [Related]
14. The performance and yield of tuberculosis testing algorithms using microscopy, chest x-ray, and Xpert MTB/RIF. Creswell J; Qin ZZ; Gurung R; Lamichhane B; Yadav DK; Prasai MK; Bista N; Adhikari LM; Rai B; Sudrungrot S J Clin Tuberc Other Mycobact Dis; 2019 Feb; 14():1-6. PubMed ID: 31720409 [TBL] [Abstract][Full Text] [Related]
15. Discordant results of Xpert MTB/Rif assay and BACTEC MGIT 960 liquid culture to detect Mycobacterium tuberculosis in community screening in Vietnam. Nguyen HV; de Haas P; Nguyen HB; Nguyen NV; Cobelens FGJ; Mirtskhulava V; Finlay A; Van Nguyen H; Huyen PTT; Tiemersma EW BMC Infect Dis; 2022 May; 22(1):506. PubMed ID: 35641936 [TBL] [Abstract][Full Text] [Related]
16. Outcomes of HIV-positive patients with non-tuberculous mycobacteria positive culture who received anti-tuberculous treatment in Botswana: Implications of using diagnostic algorithms without non-tuberculous mycobacteria. Agizew T; Boyd R; Mathebula U; Mathoma A; Basotli J; Serumola C; Pals S; Finlay A; Lekone P; Rankgoane-Pono G; Tlhakanelo T; Chihota V; Auld AF PLoS One; 2020; 15(6):e0234646. PubMed ID: 32530972 [TBL] [Abstract][Full Text] [Related]
17. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study. Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495 [TBL] [Abstract][Full Text] [Related]
18. Active case finding of rifampicin sensitive and resistant TB among household contacts of drug resistant TB patients in Andhra Pradesh and Telangana states of India - A systematic screening intervention. Chatla C; Jaju J; Achanta S; Samyuktha R; Chakramahanti S; Purad C; Chepuri R; Nair SA; Parmar M Indian J Tuberc; 2018 Jul; 65(3):218-224. PubMed ID: 29933863 [TBL] [Abstract][Full Text] [Related]
19. Intensified tuberculosis case finding among HIV-infected persons using a WHO symptom screen and Xpert(®) MTB/RIF. Adelman MW; Tsegaye M; Kempker RR; Alebachew T; Haile K; Tesfaye A; Aseffa A; Blumberg HM Int J Tuberc Lung Dis; 2015 Oct; 19(10):1197-203. PubMed ID: 26459533 [TBL] [Abstract][Full Text] [Related]
20. Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing. Peter J; Theron G; Chanda D; Clowes P; Rachow A; Lesosky M; Hoelscher M; Mwaba P; Pym A; Dheda K; BMC Infect Dis; 2015 Jul; 15():262. PubMed ID: 26156025 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]